COMMUNICATION POUR L’INTRODUCTION DU VACCIN HPV EN MAURITANIE

COMMUNICATION FOR THE INTRODUCTION OF THE VACCINE AGAINST HUMAN PAPILLOMA VIRUS IN MAURITANIA

In Mauritania, tens of thousands of girls will soon be protected against cervical cancer.

 

Mauritania is committed to protecting tens of thousands of young girls from cervical cancer every year through vaccination against human papillomavirus. 

EpiLinks supports the national immunization program to identify the most appropriate strategies for equitable and sustainable access to vaccination. The objective is that every girl in the country benefits from HPV vaccination, regardless of her level of education, her social status or her residential area. 

We conduct a feasibility and acceptability study that will enable Mauritanian health authorities and partners defining optimal operational approaches for vaccination and communication strategy and activities. We support the country in developing the communication plan that considers the specificities of HPV immunization and the perceptions and practices of beneficiaries and stakeholders.  

To implement this project, EpiLinks combines three main expertise: anthropology, communication for health and immunization systems. The team is composed of international and Mauritanian experts, specialized in reproductive health and introduction of new vaccines, and works closely with health authorities and partners, following international ethical standards in the social sciences research.

Informations

Date: 7 mois (2018-2019)
Responsible:

Elise Guillermet

Location: Africa

Resources